# BLOOM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management

> **NCT00395135** · PHASE3 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 3182 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Lorcaserin 10 mg BID
- **DRUG:** Matching Placebo BID

## Key facts

- **NCT ID:** NCT00395135
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 3182 (ACTUAL)
- **Last updated:** 2019-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00395135

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00395135, "BLOOM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00395135. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*